ACCESSIBILITY

24/7

Headlines

12:54

From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey

11:21

Mixpanel is here to help gaming companies democratize their data

09:10

Here’s how gaming brands can reach wider audiences: “Never make assumptions!”

09:01

Israel’s gaming sector is 2% of its GDP - so why is the government ignoring it?

Buzz

Most popular

Daily

Weekly

Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?

Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"

Windward acquired for $270M by FTV Capital, doubling its IPO valuation

8 Israeli cyber companies travel to the UK for collaboration opportunities

$41B in exits: Why Israeli cyber startups are a global powerhouse

More news

Reorganization

16 stories about Reorganization

Alon Bar-Shany to leave HP Indigo after 25 years

09.06.20|Golan Hazani

HP has long been attempting to carry out a restructuring but Bar-Shany has vehemently opposed it, said a person familiar with the move

Teva to Close Missouri Plant, Report Says

29.08.19|Tzally Greenberg

Teva’s manufacturing plant in Israeli city Netanya is also slated for final closure in early 2020, as part of the company’s reorganization plan

PayPal Cutting Workforce in Israel As Part of Global Reorganization

04.03.19|Meir Orbach

The company has summoned 30 of its 250 Israeli employees for a pre-termination hearing on Monday

Teva Signs Deal to Sell Closed Israeli Factory

03.02.19|Lilach Baumer

In December 2017, Teva announced plans to sell or close many of its manufacturing facilities and let 25% of global employees go as part of a debt management plan

Teva Outsources Manufacturing in Anticipation of Israeli Plant Closure

27.08.18|Golan Hazani

The debt-laden drugmaker announced an aggressive reorganization plan in December, consisting of wide-spread asset divestments and layoffs, including in its home country of Israel

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich

Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich

The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich

In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need

מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

After Announcing Restructuring Plan, Teva's Board of Directors Takes Paycut

11.01.18|Lilach Baumer

In December, the generic drugmaker announced a plan to let go 14,000 employees

As Part of Cost-Cutting Plan, Teva Will Shut Down Twenty or More Manufacturing Sites

10.01.18|Lilach Baumer

The drugmaker will shut down 20-25 manufacturing sites in the next two years, CEO Kåre Schultz said Monday

Digital Marketing Company Matomy Media Replaces CEO after Ten Months

09.01.18|Lilach Baumer

Current CEO Sagi Niri has carried out a reorganization plan in 2017, selling non-core assets and streamlining the company's operations

עובדי טבע חוסמים את אזור הכניסה ל ירושלים

Teva CEO to Netanyahu: Layoffs will Proceed as Planned

19.12.17|Omri Milman

In a statement, the company said it rejects the Israeli government’s appeal to withdraw cutback plans

Following Restructuring Announcements, Teva Reinstated as Israel’s Biggest Company

18.12.17|Lilach Baumer

Teva's stock jumped 18.7% on the New York Stock Exchange between Thursday market opening and Friday market close. Israeli Prime Minister Benjamin Netanyahu is expected to meet with CEO Kåre Schultz Tuesday

אחרי ה שביתה נתב"ג טבע פיטורים טיסות טרמינל

Tel Aviv Airport, Stock Market Open as Solidarity Strike Ends

17.12.17|Lior Gutman, Omri Milman and Micky Grunfeld

Israel’s largest labor union called for a half-day strike on Thursday, in support of Teva employees

Former Chairman Yitzhak Peterburg Leaves Teva

13.12.17|Lilach Baumer

Mr. Peterburg was the troubled drugmaker's interim CEO between February and November 1, when Kåre Schultz took helm

New CEO Steers Teva Back to Generics

28.11.17|Golan Hazani and Dror Reich

A reorganization plan announced by the company Monday would see the troubled drugmaker return to its core competencies, despite market pressures